Page last updated: 2024-10-28

hydroxyzine and AIDS Seroconversion

hydroxyzine has been researched along with AIDS Seroconversion in 2 studies

Hydroxyzine: A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
hydroxyzine : A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.

Research Excerpts

ExcerptRelevanceReference
"The causes of pruritus are numerous including xerosis, drug and photoeruptions, follicular and papular eruptions as well as infestations and infections by a wide range of organisms."2.68Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation. ( Lee, RB; Skelton, HG; Smith, KJ; Wagner, KF; Yeager, J, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, KJ1
Skelton, HG1
Yeager, J1
Lee, RB1
Wagner, KF1
Harris, DW1
Ostlere, L1
Buckley, C1
Johnson, M1
Rustin, MH1

Trials

1 trial available for hydroxyzine and AIDS Seroconversion

ArticleYear
Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation.
    Dermatology (Basel, Switzerland), 1997, Volume: 195, Issue:4

    Topics: Administration, Cutaneous; Administration, Topical; Anti-Inflammatory Agents; Antipruritics; Cycloox

1997

Other Studies

1 other study available for hydroxyzine and AIDS Seroconversion

ArticleYear
Eosinophilic pustular folliculitis in an HIV-positive man: response to cetirizine.
    The British journal of dermatology, 1992, Volume: 126, Issue:4

    Topics: Cetirizine; Eosinophilia; Folliculitis; Histamine H1 Antagonists; HIV Seropositivity; Humans; Hydrox

1992